AzTrials
AzTrials

Carpal Tunnel SyndromeNCT03730376

Decision Making in Hypothetical Carpal Tunnel Syndrome

A study testing Cost Information in people with Carpal Tunnel Syndrome, run by Stanford University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Participants will be presented with a hypothetical scenario of carpal tunnel and asked to make a decision for that case. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Carpal Tunnel Syndrome
What is being tested?
Cost Information
Could I receive a placebo?
No, everyone receives an active treatment
How many people
488 participants
Where
1 siteUnited States
Study dates
1 Oct 2018to 1 Mar 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • patients presenting to hand clinic OR mturk workers
  • age 18 or older

Who cannot join

  • traumatic mechanism of injury

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Stanford Health Care

    Redwood City, California, 94063

Other trials in United States

About this study

Official title: Patient and Consumer Decision Making in a Hypothetical Case of Carpal Tunnel Syndrome

Participants will be presented with a hypothetical scenario of carpal tunnel and asked to make a decision for that case.

Read the detailed description

Participants will be randomized into 1 of 2 groups and receive a hypothetical scenario of carpal tunnel, with or without cost information, and asked to decide if that hypothetical patient should undergo a carpal tunnel release.

Being tested
Cost Information
Medical subject headings
Carpal Tunnel Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Cost InformationOther

    participants will be given information on the personal and societal costs

Study groups in NCT03730376
Study groupRoleWhat they receive
ControlNo interventionParticipants in the control group will be given a hypothetical scenario about carpal tunnel syndrome and asked to make a treatment decision for that hypothetical patient.
InterventionExperimentalParticipants in the intervetion group will be given a hypothetical scenario about carpal tunnel syndrome as well as information about the cost of treatment and asked to make a treatment decision for that hypothetical patient.
Receives: Other: Cost Information

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Decision to have Treatment

    Participants are asked to answer "Should you get surgery right now," with the options of definitely yes, probably, maybe, maybe not, probably not, and definitely not

    Measured: immediately after completing survey

Secondary outcomes (1)
  1. Opinion on healthcare costs

    a 7 item, likert response questionnaire used to elicit participant opinions on cost in health care. This is a non-validated tool.

    Measured: immediately after completing survey

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Nov 2018
  2. Study start1 Oct 2018
  3. Primary completion1 Feb 2019
  4. Study completion1 Mar 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants will be randomized into 1 of 2 study arms arm 1: control arm 2: intervention. We will use a random block generator to assign participants to their study arm.
Masking
Double blind
Who is masked
Participant, Care provider
Enrolment
488 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03730376
Sponsor's protocol ID
47392, 47580
Status last verified
Mar 2020
First submitted
2 Nov 2018
Last updated
19 Mar 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Cost Information in people with Carpal Tunnel Syndrome, run by Stanford University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Mar 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Decision to have Treatment (time frame: immediately after completing survey). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Mar 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in